(Q40492904)

21 September 2017

title

ACAT inhibition reverses LCAT deficiency and improves plasma HDL in chronic renal failure (English)

1 reference

21 September 2017

N D Vaziri

1

1 reference

21 September 2017

K Liang

series ordinal

2

1 reference

21 September 2017

publication date

27 July 2004

1 reference

American Journal of Physiology - Renal Physiology

21 September 2017

published in

1 reference

21 September 2017

volume

287

1 reference

21 September 2017

issue

5

1 reference

21 September 2017

page(s)

F1038-43

1 reference

Identification of a form of acyl-CoA:cholesterol acyltransferase specific to liver and intestine in nonhuman primates

21 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00150.2004

Lipoprotein metabolism and renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00150.2004

Premature cardiovascular disease in chronic renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00150.2004

ACAT-2, a second mammalian acyl-CoA:cholesterol acyltransferase. Its cloning, expression, and characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00150.2004

Lipid abnormalities in uremia, dialysis, and transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00150.2004

Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00150.2004

Abnormalities in hepatic lipase in chronic renal failure: role of excess parathyroid hormone

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00150.2004

Gene expression of hepatic cholesterol 7 alpha-hydroxylase in the course of puromycin-induced nephrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00150.2004

Role of secondary hyperparathyroidism in the genesis of hypertriglyceridemia and VLDL receptor deficiency in chronic renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00150.2004

HMG-CoA reductase, cholesterol 7alpha-hydroxylase, LCAT, ACAT, LDL receptor, and SRB-1 in hereditary analbuminemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00150.2004

Upregulation of acyl-CoA: cholesterol acyltransferase in chronic renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00150.2004

Characterization of two human genes encoding acyl coenzyme A:cholesterol acyltransferase-related enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00150.2004

Acyl-coenzyme A:cholesterol acyltransferase inhibition ameliorates proteinuria, hyperlipidemia, lecithin-cholesterol acyltransferase, SRB-1, and low-denisty lipoprotein receptor deficiencies in nephrotic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00150.2004

Down-regulation of tissue lipoprotein lipase expression in experimental chronic renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00150.2004

Down-regulation of VLDL receptor expression in chronic experimental renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00150.2004

Hepatic HMG-CoA reductase gene expression during the course of puromycin-induced nephrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00150.2004

Up-regulation of acyl-coenzyme A:cholesterol acyltransferase (ACAT) in nephrotic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00150.2004

Down-regulation of hepatic lecithin:cholesterol acyltransferase gene expression in chronic renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00150.2004

Molecular mechanisms of altered cholesterol metabolism in rats with spontaneous focal glomerulosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00150.2004

10.1152/AJPRENAL.00150.2004

21 January 2018

Identifiers

DOI

1 reference

21 September 2017

1 reference